Chylomicron-bound endotoxin selectively inhibits NF-κB activation in rat hepatocytes

Shock

Volumn 18, Issue 2, 2002, Pages 182-188

  Kumwenda, Zindaba L ^a   Wong, Cindy B ^a   Johnson, Jennifer A ^a   Gosnell, Jessica E ^b   Welch, William J ^a   Harris, Hobart W ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Cytokines; Innate immunity; Liver; Rodent; Sepsis; Triglyceride rich lipoproteins

Indexed keywords

CHYLOMICRON; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; IMMUNOBLOTTING; LIVER CELL; MALE; METABOLISM; PATHOPHYSIOLOGY; PROBABILITY; RAT; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CHYLOMICRONS; DISEASE MODELS, ANIMAL; ENDOTOXINS; HEPATOCYTES; IMMUNOBLOTTING; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROBABILITY; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SHOCK, SEPTIC;

EID: 0036690208     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200208000-00016     Document Type: Article

References (42)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Clin Care Med 29(7):1303-1310, 2001.
2. Giroir B: Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade. Crit Care Med 21(5):780-789, 1993.
3. Moldawer L: Biology of proinflammatory cytokines and their antagonists. Crit Care Med 22(7):S3-S7, 1994.
4. Christman J, Holden E. Blackwell T: Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med. 23(5):955-963, 1995.
5. Ochoa J, Ukekwu A, Billiar T, Curran R, Cerra F, Simmons R, Peitzman A: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214(5):621-626, 1991.
6. Evans T, Carpenter A, Kinderman H, Cohen J: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock. 41:77-81, 1993.
7. Szabó C: Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 3(1):2-32, 1995.
8. Rodeberg D. Chaet M, Bass R, Arkovitz M, Garcia V: Nitric oxide: an overview. Am J Surg 170:292-303, 1995.
9. Nathan C. Sporn M: Cytokines in context. J Cell Biol 113:981-986, 1991.
10. Johnson C, Van Antwerp D, Hope TJ: An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα. EMBO J 18(23):6682-6693, 1999.
11. Bone R: Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125(8):680-687, 1996.
12. Kushner I, Mackiewicz A: Acute phase proteins as disease markers. Dis Markers 5:1-11, 1987.
13. Pannen B, Robotham J: The acute-phase response. New Horizons 3(2): 183-197, 1995.
14. Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones AL, Eichbaum EB, Bland GF, Rapp JH: Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 91(3): 1028-1034, 1993.
15. Harris HW, Grunfeld C, Feingold KR, Rapp JH: Human very low-density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 86(3):696-702, 1990.
16. Read TE, Harris HW, Grunfeld C, Feingold KR, Calhoun MC, Kane JP, Rapp JH: Chylomicrons enhance endotoxin excretion in bile. Infect Immun 61(8): 3496-3502, 1993.
17. Harris HW, Rockey DC, Chau P: Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats. Hepatology 27(5):1341-1348, 1998.
18. Westphal VO, Lüderitz O, Bister F: Über die extraktion von bakterien mit phenol/wasser. Z Naturf 7b:148-155, 1952.
19. Bissell DM, Tilles JG: Morphology and function of cells of human embryonic-liver in monolayer culture. J Cell Biol 50(1):222-231, 1971.
20. Sakaguchi K, Koide N, Asano K, Takabatake H, Matsushima H, Takenami T, Ono R, Sasaki S, Mori M, Koide Y, et al.: Promotion of spheroid assembly of adult rat hepatocytes by some factor(s) present in the initial 6-hour conditioned medium of the primary culture. Pathobiology 59(5):351-356, 1991.
21. Tong JZ, De Lagausie P, Furlan V, Cresteil T, Bernard O, Alvarez F: Long-term culture of adult rat hepatocyte spheroids. Exp Cell Res 200(2):326-332, 1992.
22. Tong JZ, Sarrazin S, Cassio D, Gauthier F, Alvarez F: Application of spheroid culture to human hepatocytes and maintenance of their differentiation "letter." Biol Cell 81(1):77-81, 1994.
23. Gosnell J, Wong C, Welch W, Harris H: The extracellular matrix can regulate the hepatocellular response to cytokines. J Surg Res 90(1):1-8, 2000.
24. Labarca C, Paigen K: A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102(2):344-352, 1980.
25. Muller A, Gunther D, Dux F, Naumann M, Meyer TF, Rudel T: Neisserial porin (PorB) causes rapid calcium influx in target cells and induces apoptosis by the activation of cysteine proteases. EMBO J 18(2):339-352, 1999.
26. Ji ZS, Brecht WJ, Miranda RD, Hussain MM, Innerarity TL, Mahley RW: Role of heparin sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem 268(14): 10160-10167, 1993.
27. Ji ZS, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW: Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biol Chem 269(18): 13429-13436, 1994.
28. Ji ZS, Mahley RW: Lactoferrin binding to heparin sulfate proteoglycans and the LDL receptor-related protein: further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler Thromb 14(12): 2025-2031, 1994.
29. Ji ZS, Sanan DA, Mahley RW: Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparin sulfate proteoglycans. J Lipid Res 36(3):583-592, 1995.
30. Hussain MM, Innerarity TL, Brecht WJ. Mahley RW: Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits: saturation of the sequestration step of the remnant clearance pathway. J Biol Chem 270(15):8578-8587, 1995.
31. Mahley RW, Ji ZS: Remnant lipoprotein metabolism: key pathways involving cell-surface heparin sulfate proteoglycans and apolipoprotein E. J Lipid Res 40(1):1-16, 1999.
32. Krempler F, Kostner GM, Friedl W, Paulweber B, Bauer H, Sandhofer F: Lipoprotein binding to cultured human hepatoma cells. J Clin Invest 80(2): 401-408, 1987.
33. Harris HW, Eichbaum EB, Kane JP, Rapp JH: Detection of endotoxin in triglyceride-rich lipoproteins in vitro. J Lab Clin Med 118(2): 186-193, 1991.
34. Eichbaum EB, Harris HW, Kane JP, Rapp JH: Chylomicrons can inhibit endotoxin activity in vitro. J Surg Res 51(5):413-416, 1991.
35. 15N]nitrate in biological fluids. Anal Biochem 126(1):131-138, 1982.
36. Essani NA, McGuire GM, Manning AM, Jaeschke H: Endotoxin-induced activation of the nuclear transcription factor κB and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J Immunol 156(8):2956-2963, 1996.
37. Goldring CE, Reveneau S, Pinard D, Jeannin JF: Hyporesponsiveness to lipopolysaccharide alters the composition of NF-KB binding to the regulatory regions of inducible nitric oxide synthase gene. Eur J Immunol 28(9):2960-2970, 1998.
38. Ziegler-Heitbrock HW, Sternsdorf T, Liese J, Belohradsky B, Weber C, Wedel A, Schreck R. Bauerle P, Strobel M: Pyrrolidine dithiocarbamate inhibits NF-KB mobilization and TNF production in human monocytes. J Immunol 151(12):6986-6993, 1993.
39. Ziegler-Heitbrock HW, Wedel A, Schraut W, Strobel M, Wendelgass P, Sternsdorf T, Bauerle PA, Haas JG, Riethmuller G: Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimers. J Biol Chem 269(25):17001-17004, 1994.
40. Malinin NL, Boldin MP, Kovalenko AV. Wallach D: MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385(6616):540-544, 1997.
41. Nemoto S, DiDonato JA, Lin A: Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase. Mol Cell Biol 18(12):7336-7343, 1998.
42. Goldring CE, Reveneau S. Pinard D, Jeannin JF: Hyporesponsiveness to lipopolysaccharide alters the composition of NF-κB binding to the regulatory regions of inducible nitric oxide synthase gene. Eur J Immunol 28(9):2960-2970, 1998.